LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 1,864 pages found matching %3Cscript%3Ealert%28%27What_Security?%27%29%3C/script%3E- Accutane still a Top Seller for Hoffman-LaRoche
Aug-25-06 Accutane, manufactured by Hoffman-LaRoche, was FDA approved in 1982, only to treat the most severe form of acne. Yet by 1998, the medication was the company's second-largest-selling drug, with about $800 million in sales. Accutane (Isotretinoin) entered the market in the US in 1982, and has been at the center of one firestorm after another ever since. It... - False advertising for Pantene has upset People around the World
Aug-24-06 People from around the world have been upset by false advertising claims about Pantene Pro-V shampoo. Last year, Proctor & Gamble was accused two times of falsely advertising its products in China. In the case of Pantene Pro-V, an advertising standards agency ordered the commercial be taken off the air. Additionally, the Advertising Standards Authority... - Fen-Phen May Cause Rummage Sale of Wyeth Assets - Fen-Phen Trial Resources
Aug-23-06 On August 18, 2006, Bloomberg News reported that Wyeth has faced more than 175,000 claims since fen-phen was removed from the market, and that over the past 9 years, the company has settled many claims without forcing fen-phen users to file a lawsuit. All total, the company has set aside more than $21 billion to cover legal costs and settlements since... - Lawmakers sever ties between CDC and Big Pharma
Aug-21-06 In the wake of overhauling the FDA, lawmakers are also cracking down on conflicts of interest within the Centers for Disease Control. Last month, Representatives, Dr Dave Weldon (R-FL), and Carolyn Maloney (D-NY), held a press conference to announce the introduction of a bill that would give responsibility for vaccine safety to an independent agency withi... - Lawmakers say FDA better Clean Up its Act
Aug-18-06 For six years, the Bush administration has placed pharmaceutical industry interests ahead of public interest by appointing persons with strong ties to drug companies to high level positions at the FDA. As a result, Congressional investigations and a recent survey indicate that the health and safety of all Americans is being compromised. On July 20, 200... - Merck keeps right on pushing Fosamax
Aug-11-06 New York, NY Merck's second-best selling drug, Fosamax , has been linked to jaw bone death, although sales of the drug remain steady with no decrease whatsoever. Jaw bone deth is a condition that can involve severe pain, infection, loose teeth, exposed bone, loss of function and disfigurement, according to the American Association of Oral and Maxillofa... - Ortho Evra: Too much Estrogen can be a Bad Thing
Aug-9-06 The makers of Ortho Evra are learning that there is such a thing as too much estrogen, as more and more lawsuits are being filed against them. The latest lawsuit is a class action suit in Canada, filed July 28, 2006 in London, Ontario. At issue is the amount of the hormone estrogen that women who use Ortho Evra are exposed to. According to a news release... - Lawsuits Multiply For Johnson & Johnson's Charite Spine Disc
Aug-7-06 According to the Institute of Medicine, over a million Americans are severely injured each year by medical devices. In 2002 alone, the FDA received more than 111,000 reports of adverse events involving medical devices. That number has increased since the Charite artificial spinal disc was approved for use in the US in October 2004. As of July 2006,... - Natrecor: A History of Shady Practices
Aug-6-06 It's incredulous that a drug approved for very limited use could actually be given to a wide range of people. Yet this is what happened in the case of Natrecor (nesiritide), a drug approved by the FDA for emergency use only in hospitals. Somehow, Natrecor managed to evolve from emergency-only to preventative-maintenance use, despite not receiving FDA appr... - Credit Card Abuse: How Universal Default Affects You
Aug-6-06 You may not be aware of it, but the credit card companies are watching you. Even if you already knew this, they are probably watching more closely than you think. In addition to watching your every move on their product, they are also watching when you pay your bills, whether or not you apply for other credit cards, and whether or not your credit score ha... - Records Show Dell Aware of Laptop Fires Years Before Recall
Aug-2-06 CRN recently reported that sources supposedly from within Dell Computer Corporation confirmed that the company kept quiet for at least two years before finally recalling 22,000 notebooks last year. According to CRN's sources, Dell knew of literally dozens of cases where laptops had burst into flames before they identified the issue as a broad ranging thre... - Boston Scientific inherits Guidant Heart Device Lawsuits
Aug-1-06 According to the FDA, the reason there are not more deaths reported in patients implanted with Guidant's defective defibrillators is because most patients die outside the clinic or hospital and the devices are not sent back to the manufacturer to be checked. On June 23, 2006, Bloomberg News reported that Guidant's Contak Renewal devices might fail about 1... - Eli Lilly and Co. under fire for Zyprexa
Aug-1-06 On July 24, 2006, Mississippi became the fifth state to file a lawsuit against Eli Lilly and Co. for its sales and marketing of Zyprexa (olanzapine). The lawsuit was filed in Lafayette County Circuit Court. According to a special attorney general who is handling the case, the lawsuit was filed to recover money the state of Mississippi spent purchasin... - Paxil: A Mother's Warning
Jul-31-06 etty Johnson of Pittsburg was taking Paxil for depression but took herself off the drug three months into her pregnancy. And that may have been too late. "I am angry that the drug makers GlaxoSmithKline allowed so many people to be on Paxil. Why didn't they test Paxil more thoroughly," says Johnson. "There should have been more tests - I don't know if pregna... - GlaxoSmithKline Sued Over Paxil Birth Defects
Jul-29-06 A lawsuit was filed against GlaxoSmithKline on July 28, 2006, in Philadelphia on behalf of Adrian Vasquez, who was born on April 19, 2004, with birth defects as a result of his mother having been prescribed Paxil during pregnancy. Paxil belongs to the class of antidepressant drugs known as selective serotonin re-uptake inhibitors (SSRIs). At birth, Ad... - FDA Official Wants Ketek Support Withdrawn
Jul-26-06 At least one U.S. drug safety official wants Ketek taken off the shelves. The New York Times has reported that Dr. David Graham, a U.S. drug safety official with the Food and Drug Administration believes that the FDA's 2004 approval of the drug Ketek -- manufactured by Sanofi-Aventis for the treatment of acute upper respiratory tract diseases -- was a mistak... - Boston Scientific Won Guidant - What A Prize
Jul-24-06 In the second quarter of 2006, Boston Scientific may have lost 27% of its value, but in the first quarter, it did win a nearly two month bidding war with Johnson and Johnson over the heart device maker, Guidant, with a bid of $27.5 billion for the grand prize. It probably seemed like a great deal when the bidding started. Guidant's heart device division... - Bush's Mental Illness Screening Squad On the Move
Jul-9-06 The tax dollar funded mental health screening programs popping up in every corner of the nation represent an enormous gift to Big Pharma from the Bush administration. After all, drug companies can't push drugs without a lucrative customer base, so the screening programs are a great solution for that little problem. On April 29, 2002, Bush kicked off th... - Risk of Harm from Motrin, Aleve, Advil - Better Odds in a Crap Shoot
Jun-30-06 Complications from non-steroidal anti-inflammatory drugs, or NSAID, have been linked to 103,000 hospitalizations and more than 16,000 deaths per year in the US, according to a study published in the American Journal of Therapeutics. A lack of information, experts say, is the root cause of the lack of concern over the health risks associated with NSAIDs. A... - Add Triaminic Vapor Patch To List Of Dangerous Patches
Jun-25-06 On June 19, 2006, Novartis Consumer Health issued a recall for the cough-suppressing Triaminic Vapor Patches in the US, about three weeks after Health Canada issued a warning after a Canadian child who chewed on a patch suffered a seizure. There have been eight adverse events with the patch, all involving ingestion, Navartis spokesperson, Julie Masow, tol...